Release Date: 09/08/24 11:14 Summary: Final Director's Interest Notice (Gail Pemberton) Price Sensitive: No Download Document 180.93KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling